Endpoints News 9. Jan. 2026 Krystal Biotech says it can deliver native protein to cystic fibrosis patients
Endpoints News 9. Jan. 2026 Gene editing pioneers launch first startup focused on custom CRISPR therapies
Endpoints News 9. Jan. 2026 Aktis lands biotech's first IPO of 2026, raising $318M for radiopharmaceuticals
Endpoints News 8. Jan. 2026 FDA staff cuts mostly didn't impact new drug review timelines, analysis finds